Skip to main content
LXEO logo

LXEO · Lexeo Therapeutics, Inc. · Share Buybacks

Track LXEO — free
$2.87 +0.17 (+6.30%) At close · Oct 27 Q2 2026 earnings call transcript
Market Cap
$221.52M
Shares
82.05M
Volume · Oct 27 2.68M Avg daily vol (3M) 1.28M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2025-03-24 $75,000,000 — —
Key facts CIK 1907108 CUSIP 52886X107 13F (30d) 17 filings 17 filers Visit website Investor relations